Home

Λυγμός μαντήλι Πισίνα kappa opioid receptor activates p38 Σημειώ ακριβώς Μαργαρίτα Μίτσελ Μικρός οδοντωτός τροχός

Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes  for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry

Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the  Brain
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

Kappa Receptors – Opioid Peptides
Kappa Receptors – Opioid Peptides

Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and  Arrestin-dependent in Neurons and Astrocytes* - Journal of Biological  Chemistry
Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes* - Journal of Biological Chemistry

Molecular mechanisms of opioid tolerance: From opioid receptors to  inflammatory mediators (Review)
Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review)

Biased agonists of the kappa opioid receptor suppress pain and itch without  causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling

Kappa opioid receptor activation alleviates experimental autoimmune  encephalomyelitis and promotes oligodendrocyte-mediated remyelination |  Nature Communications
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination | Nature Communications

Kinase cascades and ligand-directed signaling at the kappa opioid receptor.  - Abstract - Europe PMC
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC

Opioids in cancer: The κ‑opioid receptor (Review)
Opioids in cancer: The κ‑opioid receptor (Review)

Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands:  Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience

Chronic Kappa opioid receptor activation modulates NR2B: Implication in  treatment resistant depression – topic of research paper in Clinical  medicine. Download scholarly article PDF and read for free on CyberLeninka  open science
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

Molecular mechanisms of opioid receptor-dependent signaling and behavior. -  Abstract - Europe PMC
Molecular mechanisms of opioid receptor-dependent signaling and behavior. - Abstract - Europe PMC

IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced  Abnormal Behaviors?
IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?

Constitutive activation of kappa opioid receptors at ventral tegmental area  inhibitory synapses following acute stress | eLife
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife

Nalfurafine is a G-protein biased agonist having significantly greater bias  at the human than rodent form of the kappa opioid receptor - ScienceDirect
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor - ScienceDirect

Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA  Dopamine Neurons | Journal of Neuroscience
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons | Journal of Neuroscience

IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced  Abnormal Behaviors?
IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?

Mitogen‐activated protein kinase signaling mediates opioid‐induced  presynaptic NMDA receptor activation and analgesic tolerance - Deng - 2019  - Journal of Neurochemistry - Wiley Online Library
Mitogen‐activated protein kinase signaling mediates opioid‐induced presynaptic NMDA receptor activation and analgesic tolerance - Deng - 2019 - Journal of Neurochemistry - Wiley Online Library

Constitutive activation of kappa opioid receptors at ventral tegmental area  inhibitory synapses following acute stress | eLife
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife

Agonist-induced phosphorylation bar code and differential post-activation  signaling of the delta opioid receptor revealed by phosphosite-specific  antibodies | Scientific Reports
Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies | Scientific Reports

Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic  Targets: Recent Progress and Future Perspective
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective

Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or  approach-avoidance behavior occur differentially across the nucleus  accumbens shell rostro-caudal axis - ScienceDirect
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect

Kappa opioid receptor (KOR) activation study. A): G protein activation... |  Download Scientific Diagram
Kappa opioid receptor (KOR) activation study. A): G protein activation... | Download Scientific Diagram

Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for  the Development of Potential Treatments of Pain with Reduced Side Effects
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical  Role of the Dynorphin/Kappa Opioid Receptor System
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System

Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior
Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior